Deutivacaftor manufacturers
- Ivacaftor-D9
-
-
2026-05-11
- CAS:1413431-07-8
- Purity: 99.13%
- Supply Ability: 10g
|
| | Deutivacaftor Basic information |
| Product Name: | Deutivacaftor | | Synonyms: | Ivacaftor deuterated 1413431-07-8;Ivacaftor(4-tertbutyl-d9);deutivacaftor;Ivacaftor-D-9,Ivacaftor D9,IvacaftorD9;N-(2-(tert-butyl)-5-hydroxy-4-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide;VX-561(CTP-656);Ivacaftor-d9 (VX-770-d9);CTP-656 | | CAS: | 1413431-07-8 | | MF: | C24H28N2O3 | | MW: | 392.5 | | EINECS: | | | Product Categories: | Deutivacaftor | | Mol File: | 1413431-07-8.mol |  |
| | Deutivacaftor Chemical Properties |
| solubility | DMSO (Slightly), Methanol (Slightly, Heated) | | form | Solid | | color | White to Off-White |
| | Deutivacaftor Usage And Synthesis |
| Uses | Ivacaftor (4-tertbutyl-d9) (Major) is isotopically labelled form of Ivacaftor (I940600), which is used in the treatment of cystic fibrosis. |
| | Deutivacaftor Preparation Products And Raw materials |
|